medigraphic.com
ISSN 2007-5057 (Print)
Investigación en Educación Médica

2023, Number 47

<< Back Next >>

Inv Ed Med 2023; 12 (47)

Quality of pharmaceutical industry publicity flyers and medical education

Peredo-Silva L, Reyes-Morales H, Guizar-García LA, Almeida-Gutiérrez E, Páez-Moreno R, Lifshitz A, Mino-León D

Language: Spanish
References: 22
Page: 58-66
PDF size: 481.38 Kb.


ABSTRACT

Introduction: It has been reported that 15% of the promotional products from the pharmaceutical industry (PI) include information not supported by the results of the original research.
Objective: Evaluate the validity of the scientific information that supports the data included in the pharmaceutical industry promotional brochures for internists and cardiologists and reconcile the information.
Method: Promotional brochures were collected during national conferences of Internal Medicine (IM) and Cardiology (C), and 10 promotional brochures of each medical specialty were randomly selected. Three researchers evaluated the quality of the references, and the validity of the original research and compared the information from the promotional brochure and the original publication. Descriptive statistical analysis was performed.
Results: 57 IM and 16 C promotional brochures were collected; the quality of the references of 4 promotional brochures from IM was classified as “moderate” evidence and the references of 4 promotional from C were identified as “non-scientific” evidence. Clinical trials of IM and C were evaluated as valid and an observational study of C was classified as invalid. Comparison between promotional information and the original study detected differences in four IM and four C promotions, according to the ethical criteria for the promotion of medicines by the World Health Organization (WHO) the lack of accuracy predominated, and in some cases, the information was not reliable and/or true.
Conclusions: Training in critical lectures is crucial for medical doctors. This will allow them a critical review of promotional information from PI, to identify the ones that may lead to inappropriate prescription.


REFERENCES

  1. Gagnon MA, Lexchin J. The cost of pushing pills: a newestimate of pharmaceutical promotion expenditures in theUnited States. PLoS Med. 2008;5(1):e1. doi: 10.1371/journal.pmed.0050001.

  2. Vallés J, González J. El papel de la Industria Farmacéutica.En: Vallés J, González J. Salud pública y el acceso a losmedicamentos. Sevilla: Universidad Loyola de Andalucía;2018. p. 20-24.

  3. Wazana A. Physicians and the pharmaceutical industry:is a gift ever just a gift? JAMA. 2000;283(3):373-80. doi:10.1001/jama.283.3.373.

  4. De Ferrari A, Gentille C, Davalos L, Huayanay L, MalagaG. Attitudes and relationship between physicians andthe pharmaceutical industry in a public general hospitalin Lima, Peru. PLoS One. 2014;9(6):e100114. doi: 10.1371/journal.pone.0100114.

  5. Committee on Oversight and Reform U.S. House of Representatives.Drug pricing investigation. Mayority staffreport. 2021 [consultado 15 Feb 2023]. Disponible en:https://oversight.house.gov/wp-content/uploads/2021/12/PBM-Report-12102021.pdf

  6. Lexchin J. What information do physicians receive from pharmaceuticalrepresentatives? Can Fam Physician. 1997;43:941-5.

  7. Páez R. Pautas bioéticas: la industria farmacéutica entre laciencia y el mercado. 2a edición. Ciudad de México, México:Fondo de Cultura Económica; 2018.

  8. Organización Mundial de la Salud. Comprender la promociónfarmacéutica y responder a ella. Una guía práctica. 2011[consultado 4 En 2023]. Disponible en: https://www.paho.org/es/node/38967

  9. Peay MY, Peay ER. Innovation in high risk drug therapy. SocSci Med. 1994; 39(1):39-52. doi: 10.1016/0277-9536(94)90164-3.

  10. Anderson BL, Silverman GK, Loewenstein GF, ZinbergS, Schulkin J. Factors associated with physicians’ relianceon pharmaceutical sales representatives. Acad Med.2009;84(8):994-1002. doi: 10.1097/ACM.0b013e3181ace53a.

  11. Ziegler MG, Lew P, Singer BC. The accuracy of drug informationfrom pharmaceutical sales representatives. JAMA.1995;273(16):1296-8.

  12. Cardarelli R, Licciardone JC, Taylor LG. A cross-sectionalevidence-based review of pharmaceutical promotional marketingbrochures and their underlying studies: Is what theytell us important and true? BMC Fam Pract. 2006;7:13. doi:10.1186/1471-2296-7-13.

  13. Dixon W, Massey F. Introduction to Statistical Analysis. 3rded. New York, USA: Mc Graw-Hill Book Company; 1969.

  14. Lankinen KS, Levola T, Marttinen K, Puumalainen I, Helin-Salmivaara A. Industry guidelines, laws and regulationsignored: quality of drug advertising in medical journals.Pharmacoepidemiol Drug Saf. 2004;13(11):789-95. doi:10.1002/pds.1017.

  15. Vandenbroucke JP, Von Elm E, Altman DG, Gøtzsche PC,Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger My en nombre de la Iniciativa STROBE. Mejorar la comunicaciónde estudios observacionales en epidemiología (STROBE):explicación y elaboración. Gac Sanit. 2009;23(2):158e1-158e28. doi: 10.1016/j.gaceta.2008.12.001.

  16. World Health Organization. Roadmap for access to medicines,vaccines and health product 2019-2023. Comprehensive supportfor access to medicines, vaccines and other health products.2019 [consultado 13 Feb 2023]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/330145/9789241517034-eng.pdf?sequence=1&isAllowed=y

  17. Organización Panamericana de la Salud, OrganizaciónMundial de la Salud. Red Panamericana de Armonizaciónde la Reglamentación Farmacéutica. Criterios éticos parala promoción, propaganda y publicidad de medicamentos.2013 [consultado 14 Feb 2023]. Disponible en: https://www.paho.org/hq/dmdocuments/2013/a-Red-PARF-No--12-final.PDF

  18. Organización Mundial Salud. Criterios éticos para la promociónde medicamentos. 1988 [consultado 4 En 2023].Disponible en: https://www.paho.org/bra/dmdocuments/criterios%20eticos%20para%20la%20promocion.pdf

  19. Rohra DK, Gilani AH, Memon IK, Perven G, Khan MT,Zafar H, Kumar R. Critical evaluation of the claims madeby pharmaceutical companies in drug promotional materialin Pakistan. J Pharm Pharm Sci. 2006;9(1):50-9.

  20. Buffo-Sequeira I, Arroyo-Castelán E, Halabe-Cherem J,Monroy-San Martín M. El médico y la relación con la industriafarmacéutica. Rev CONAMED. 2012; 17(4):182-6.

  21. Lee AE, Ardissino M, Bednarczuk NF, Tennyson M, KhajuriaA. Prospective assessment of a critical appraisal teachingprogramme on medical students’ confidence and performancein appraising medical literature. J R Coll PhysiciansEdinb. 2020;50(1):60-6. doi: 10.4997/JRCPE.2020.118.

  22. Nasr JA, Falatko J, Halalau A. The impact of critical appraisalworkshops on residents’ evidence based medicine skillsand knowledge. Adv Med Educ Pract. 2018;9:267-72. doi:10.2147/AMEP.S155676.




2020     |     www.medigraphic.com